In the media
September 12, 2023

(French) Techbio: Owkin turns biotech on its head thanks to artificial intelligence

Thanks to AI and the data collected, Thomas Clozel, co-founder of Owkin, wants to treat patients with tumors.

About Owkin

Owkin is an agentic AI company pioneering Biological Artificial Superintelligence to solve problems in biology where human researchers alone have failed.

Owkin builds K Pro - an AI scientist for pharmaceutical research and strategic decision-making. K Pro orchestrates a suite of AI skills and tools to decode complex biology, accelerate research, and dramatically increase productivity.

K Pro is built on Owkin’s unrivalled multimodal patient data network, state-of-the-art AI for biology and decade of of experience working with pharmaceutical partners.